CF Europe, European Respiratory Network

Slides:



Advertisements
Similar presentations
About the European Science Foundation 1 Dr. Nina Hoffman, Humanities and Social Sciences Unit, European Science Foundation.
Advertisements

¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Date: Saturday, April 28, 2007 Presented by: Carl C. Booberg Executive Director of the American Thoracic Society.
FERS Meeting 3 rd April 2009 Brussels. ERS Brussels Office Who are we? Peter Helms – EU Secretary Nadia Kamel – Scientific Officer Brian Ward – Policy.
SPANISH ASSOCIATION OF ATAXIA PATIENTS FEDAES  In 1998, we generated the ing list of Hispataxia and the webpage.  In 2000, we contacted researchers.
KOSICE September KOURIR association KOSICE September The KOURIR association  Presentation of KOURIR  Objectives n Information - Communication.
EFSA’s Mission and Priorities Bernhard Berger Head of the Advisory Forum and Scientific Cooperation Unit Conference “Importance of food additives today.
Presentation to Aontas Community Education Network By Nora Fahy Roscommon Women’s Network Community Project 24 th March 2015.
Benefits of BCC membership. Access to expert advice, guidance and support from BCC when you need it. Members enjoy immediate access to the vastly experienced.
Research & Innovation International Rare Disease Consortium: Data Sharing Policy 3 rd International Traumatic Brain Injury Research Meeting Catherine BERENS.
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
County Council Assembly Committees Democracy, Public Health and Culture Healthcare and Rehabilitation County Council Assembly Presiding committee.
The involvement of patients in Health Technology Assessment Andrzej Rys Director Health and Consumers Directorate-General Brussels 18 May 2010.
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
Stroke helplineWebsite www.stroke.org.uk Stroke helplineWebsite www.stroke.org.uk.
BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.
5th Emergency Services Workshop, October 2008 Update on 112 and EU Regulatory Issues Gary Machado Secretary of EENA Advisory Board.
The European Science Foundation is a non-governmental organisation based in Strasbourg, France.
HOW TO BECOME A WILSON’S DISEASE TISSUE DONOR Advancing the procurement, preservation and distribution of human tissues and organs for biomedical research.
The Concept of the European Platform of Women Scientists An instrument of support and a way to become active in the policy debate Isabel Beuter, M.A. Center.
A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE Annual General Meeting Working group sessions Annual General Meeting Working group sessions.
ERN EUROPEAN REFERENCE NETWORK FOR THE TREATMENT OF RARE DISEASES.
Federation for Healthcare Science (FHCS). Scientific/Technical/Therapy 10% NHS workforce data 2003: Total of 1.3M people employed 1.1M of these involved.
The impact on practice, costs and outcomes of New Roles for health professionals in Europe (MUNROS) Antoinette de Bont/ associate professor/ Erasmus University.
South East Wales Critical Care Network Dr George Findlay, Lead Clinician Jennie Willmott, Network Manager.
Building partnerships The Velma E. Schmidt Critical Childhood Public Policy Research Initiative and other international collaborations in early childhood.
Harvinaiset – The Finnish Network for Rare Diseases Saara Paajanen - Finnish Association of People with Physical Disabilities Pia Mölsä - The Finnish Association.
IHE PCD Analysis Committee Meeting October 26, 2009.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
The role of UEMO In General Practice in Europe Dr Claudio Cricelli.
EURORDIS Eurordis Position on Research Priorities for Rare Diseases.
Patient Groups & Consumer Champion Julian Maw Chair of Harrow LINk.
Communications Strategy 1 ATTRACT Core Consortium Meeting CERN, Geneva, 3 rd November 2015 Science|Business Richard L. Hudson, CEO &
The impact on practice, costs and outcomes of New Roles for health professionals in Europe (MUNROS) Antoinette de Bont Erasmus University Rotterdam European.
IIER-ISCIII Madrid, March 2013 Rare respiratory diseasesregistries included in SpainRDRSociedad Española de Neumología yCirugía Torácica (SEPAR) Beatriz.
Adrian M Agius Meeting of UEMS with Medical Specialist Societies Brussels 1 March 2014.
IMPRINT – EUROPE Professor Chris Nash (Institute for Transport Studies University of Leeds) Coordinator.
Activities in Rare Heart Diseases Project Sami Kaivos Cardiovascular nurse.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
The European Science Foundation is a non-governmental organisation based in Strasbourg, France.
Making the future happen Some remarks from the perspective of the Reykjavik-Group Chair full report:
Richard Murrugarra – Centurion
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
Euro-HSP - GA 2017 – June 17 – 18 - Alghero, Sardinia
A potential European Research Infrastructure on Rare Diseases and perspectives for enhancing international cooperation IRDIRC Executive Committee, Miami,
Future Earth Engagement Committee SciDataCon 2016 – September
Notes for use These slides summarise the BLF report on our work in The full report with more detail can be found at The slides.
Patient involvement in ERS Task Forces
ELF website & European Patient Ambassador Programme (EPAP)
Respiratory MCNs - Interstitial lung diseases
National Workshop on Rare Disease Centres of Reference
Kaplan–Meier survival curves of interstitial pneumonia with autoimmune features (IPAF) with usual interstitial pneumonia (UIP) pattern (on high-resolution.
Are we ready for the next call of ERNs?
ČIPA – Czech Initiative for Asthma
SCIE Copenhagen. Jeni Bremner David Somekh 12 April 2018.
Representative images of immunohistochemical staining of discoidin domain receptor (DDR)2 in interstitial lung disease (ILD) other than idiopathic pulmonary.
Comparative expression of discoidin domain receptors (DDRs) between healthy lung tissues and those from different types of interstitial lung disease (ILD):
Patient Organisation Day, ERS Congress, September 2018
CPME Activities UEMS Council meeting Dr Jacques de HALLER
Enabling community pharmacy evolution
PHA Europe and ELF Council
Raising the bar Meeting Europe’s future challenges
The Network of European Patient Advocacy Groups is the only umbrella organization for patient groups committed to gynaecological cancers. Established in.
Phosphorylation levels of discoidin domain receptor (DDR)2.
Prevalence of different aetiologies of pulmonary hypertension (PH) in the paediatric population (results from national registries and paediatric cohorts).
Topic 2 – Reform Documents 4(4) and 4(5)(Cg-18)
COUNTERPOINT: Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? No 
Pulmonary angiography in the right lung (a, c, e and g) and the left lung (b, d, f and h) of a patient with chronic thromboembolic pulmonary hypertension.
This schematic view of the morpho-functional unit of the lung (alveolus) depicts the main differences in cellular composition in idiopathic pulmonary fibrosis.
Subtypes of ILD in pre-MDT and post-MDT cohorts.
Presentation transcript:

CF Europe, European Respiratory Network Hilde de Keyser CF Europe, European Respiratory Network

ERN-LUNG Application for European Commission funding (€200,000) To establish a European Reference Network on rare lung conditions (ERN-LUNG): To join together medical experts and specialist centres across Europe To share knowledge and resources for patient-centred research and care of rare and complex lung conditions With patients at the heart of the network Awaiting EC decision EURORDIS coordinating patient input across ERNs

CF Core Network: CF Europe + 2 patients Advisory Board ELF, ERS, policy-makers, foundations, trade organisations, ethics specialists etc. Advisory Board ELF, ERS, policy-makers, foundations, trade organisations, ethics specialists etc. Functional Committees To include independent patient representatives –identified via the advisory board application process or another application process. Patient Assembly ILD Core Network: EURO-IPFF + 2 patient s To incl. IPF, Sarcoidosis, Pulmonary Alveolar Proteinosis, Connective Tissue Diseases, LAM PCD Core Network: One patient org rep nominated by the available national orgs + 2 patients CF Core Network: CF Europe + 2 patients PH Core Network: PHA Europe + 2 patients NCFBE Core Network: ELF Patient Advisory Group Alpha 1 Core Network: Alpha Global + 2 patients Meso Core Network: One patient org rep nominated by the available national orgs + 2 patients Fillipo Martone Bernd Quadder Hilde de Keyser Bernd Quadder Luc Matthysen Gergely Meszaros